Literature DB >> 33513875

Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy.

Christoph Zurl1,2,3, Martin Hoenigl1,4, Eduard Schulz5, Stefan Hatzl5, Gregor Gorkiewicz3,6, Robert Krause1,3, Philipp Eller7, Juergen Prattes1.   

Abstract

Viral infections can cause acute respiratory distress syndrome (ARDS), consequently leading to susceptibility for secondary pulmonary infections. Over the past few weeks, a number of studies have reported on secondary pulmonary aspergillosis complicating severe COVID-19. We report the case of a 53-year old male patient with secondary acute myeloid leukemia (AML) who suffered from COVID-19 ARDS and was diagnosed postmortem with mucormycosis.

Entities:  

Keywords:  COVID-19; co-infections; fungal infections; mucormycosis

Year:  2021        PMID： 33513875     DOI： 10.3390/jof7020088

Source DB:  PubMed          Journal:  J Fungi (Basel)        ISSN： 2309-608X


  41 in total

Review 1.  Mucormycosis in COVID-19: A systematic review of literature.

Authors:  Shivaraj Nagalli; Nidhi Shankar Kikkeri
Journal:  Infez Med       Date:  2021-12-10

Review 2.  CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.

Authors:  Mandeep Garg; Nidhi Prabhakar; Valliappan Muthu; Shameema Farookh; Harsimran Kaur; Vikas Suri; Ritesh Agarwal
Journal:  Radiology       Date:  2021-08-31       Impact factor: 11.105

3.  Pneumonitis and Pulmonary Mucormycosis in a Covid-19 Positive Patient-A Case Report.

Authors:  Luv Sharma; Sumiti Gupta; Lalit Chopra; Pooja Dhamija
Journal:  Acad Forensic Pathol       Date:  2022-06-15

Review 4.  Current Treatment Options for COVID-19 Associated Mucormycosis: Present Status and Future Perspectives.

Authors:  Yasasve Madhavan; Kadambari Vijay Sai; Dilip Kumar Shanmugam; Aashabharathi Manimaran; Karthigadevi Guruviah; Yugal Kishore Mohanta; Divyambika Catakapatri Venugopal; Tapan Kumar Mohanta; Nanaocha Sharma; Saravanan Muthupandian
Journal:  J Clin Med       Date:  2022-06-23       Impact factor: 4.964

5.  COVID-19-associated fungal infections in Iran: A systematic review.

Authors:  Tina Nazari; Fatemeh Sadeghi; Alireza Izadi; Setayesh Sameni; Shahram Mahmoudi
Journal:  PLoS One       Date:  2022-07-11       Impact factor: 3.752

6.  Bronchial wall necrosis secondary to mucormycosis following SARS-Cov2 infection: A case report.

Authors:  Ghazal Arjmand; Elham Askari; Arya Kazemi; Ehsan Zarei; Sara Haseli; Nazanin Sadraei
Journal:  Radiol Case Rep       Date:  2022-06-17

Review 7.  High mortality co-infections of COVID-19 patients: mucormycosis and other fungal infections.

Authors:  Kinal Bhatt; Arjola Agolli; Mehrie H Patel; Radhika Garimella; Madhuri Devi; Efrain Garcia; Harshad Amin; Carlos Domingue; Roberto Guerra Del Castillo; Marcos Sanchez-Gonzalez
Journal:  Discoveries (Craiova)       Date:  2021-03-31

8.  Pulmonary aspergillosis and mucormycosis in a patient with COVID-19.

Authors:  Andre K Johnson; Zeron Ghazarian; Kristina D Cendrowski; Jon G Persichino
Journal:  Med Mycol Case Rep       Date:  2021-04-07

9.  Autoptic identification of disseminated mucormycosis in a young male presenting with cerebrovascular event, multi-organ dysfunction and COVID-19 infection.

Authors:  Vidya Krishna; Jaymin Morjaria; Rona Jalandari; Fatima Omar; Sundeep Kaul
Journal:  IDCases       Date:  2021-05-28

10.  Mucormycosis: An opportunistic pathogen during COVID-19.

Authors:  Iyer Mahalaxmi; Kaavya Jayaramayya; Dhivya Venkatesan; Mohana Devi Subramaniam; Kaviyarasi Renu; Padmavathi Vijayakumar; Arul Narayanasamy; Abilash Valsala Gopalakrishnan; Nachimuthu Senthil Kumar; Palanisamy Sivaprakash; Krothapalli R S Sambasiva Rao; Balachandar Vellingiri
Journal:  Environ Res       Date:  2021-07-06       Impact factor: 6.498
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.